TRANSGENIC MICE OVEREXPRESSING TYPE-2 NITRIC-OXIDE SYNTHASE IN PANCREATIC BETA-CELLS DEVELOP INSULIN-DEPENDENT DIABETES WITHOUT INSULITIS

Citation
T. Takamura et al., TRANSGENIC MICE OVEREXPRESSING TYPE-2 NITRIC-OXIDE SYNTHASE IN PANCREATIC BETA-CELLS DEVELOP INSULIN-DEPENDENT DIABETES WITHOUT INSULITIS, The Journal of biological chemistry, 273(5), 1998, pp. 2493-2496
Citations number
36
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
273
Issue
5
Year of publication
1998
Pages
2493 - 2496
Database
ISI
SICI code
0021-9258(1998)273:5<2493:TMOTNS>2.0.ZU;2-Y
Abstract
We generated transgenic mice carrying the mouse type 2 nitric oxide sy nthase (NOS2) cDNA under the control of the insulin promoter. Western and immunohistochemical analyses revealed that NOS2 was expressed abun dantly in transgenic islets but not in control islets. When islets wer e isolated and cultured, high levels of nitrite were released from the transgenic islets, In transgenic mice, the beta cell mass was markedl y reduced without the infiltration of macrophages or lymphocytes, and extensive DNA strand breaks were detected in the islets by in situ nic k translation, All the transgenic mice developed hypoinsulinemic diabe tes by 4 weeks of age, and treatment with an inhibitor of NOS2, aminog uanidine (200 mg/kg body weight every 12 h), prevented or delayed the development of diabetes. The present study shows that the production o f nitric oxide by beta cell NOS2 plays an essential role in the beta c ell degeneration.